These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 31818265)

  • 1. TORCH screening used appropriately in China?─three years results from a teaching hospital in northwest China.
    Wang LC; Yan F; Ruan JX; Xiao Y; Yu Y
    BMC Pregnancy Childbirth; 2019 Dec; 19(1):484. PubMed ID: 31818265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serological Screening of TORCH Pathogen Infections in Infertile Women of Childbearing Age in Northwest China.
    Ren X; Wang K; Chang Z; Liu M; Cheng F; Min B; Wei S
    Reprod Sci; 2024 Sep; 31(9):2877-2884. PubMed ID: 38630173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seroepidemiology of TORCH antibodies in the reproductive-aged women in China.
    Qi Y; Zhu S; Li C; Wu H; Yue H; Zhang Y; Zhu B; Ma J; Feng Z; Kong H; Cai X; Ruan Q
    Eur J Obstet Gynecol Reprod Biol; 2020 Nov; 254():114-118. PubMed ID: 32957008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of preconception TORCH infections and its influential factors: evidence from over 2 million women with fertility desire in southern China.
    Han L; Li R; Xiong W; Hu Y; Wu J; Liu X; Nie H; Qin W; Ling L; Li M
    BMC Womens Health; 2023 Aug; 23(1):425. PubMed ID: 37563634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seroprevalence of TORCH infections in women of childbearing age in Croatia.
    Vilibic-Cavlek T; Ljubin-Sternak S; Ban M; Kolaric B; Sviben M; Mlinaric-Galinovic G
    J Matern Fetal Neonatal Med; 2011 Feb; 24(2):280-3. PubMed ID: 20476874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of toxoplasmosis, rubella, cytomegalovirus, and herpes (TORCH) infections among women attending the antenatal care clinic, maternity hospital in Abha, Southwestern Saudi Arabia.
    Al-Hakami AM; Paul E; Al-Abed F; Alzoani AA; Shati AA; Assiri MI; Qasim AA; Riaz F; Moosa RA; Chandramoorthy HC
    Saudi Med J; 2020 Jul; 41(7):757-762. PubMed ID: 32601646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seroprevalence of Toxoplasma gondii, rubella and cytomegalovirus among pregnant women in western region of Turkey.
    Tamer GS; Dundar D; Caliskan E
    Clin Invest Med; 2009 Feb; 32(1):E43-7. PubMed ID: 19178878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seroepidemiology of TORCH Infections among 1.7 Million Women of Childbearing Age in Rural China: A Population-Based Cross-Sectional Study.
    Qin X; Zhang S; Liu H; Cheng G; Liu Y; Hu M; Liu N; Zhang M
    Am J Trop Med Hyg; 2021 Sep; 105(5):1202-1209. PubMed ID: 34544045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The epidemiology and disease burden of congenital TORCH infections among hospitalized children in China: A national cross-sectional study.
    Zhang L; Wang X; Liu M; Feng G; Zeng Y; Wang R; Xie Z
    PLoS Negl Trop Dis; 2022 Oct; 16(10):e0010861. PubMed ID: 36240247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seroprevalence and age-related susceptibility of TORCH infections in childbearing age women: A 5-year cross-sectional retrospective study and a literature review.
    Pavia G; Licata F; Marascio N; Giancotti A; Tassone MT; Costa C; Scarlata GGM; Prestagiacomo LE; Gigliotti S; Trecarichi EM; Torti C; Bianco A; Quirino A; Matera G
    J Infect Public Health; 2024 Oct; 17(10):102537. PubMed ID: 39255545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is screening of TORCH worthwhile in women with bad obstetric history: an observation from eastern Nepal.
    Kumari N; Morris N; Dutta R
    J Health Popul Nutr; 2011 Feb; 29(1):77-80. PubMed ID: 21528793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Screening of
    Nabizadeh E; Ghotaslou A; Salahi B; Ghotaslou R
    Infect Dis Obstet Gynecol; 2022; 2022():4490728. PubMed ID: 35046632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for TORCH infections in pregnant women: a report from Delhi.
    Kaur R; Gupta N; Nair D; Kakkar M; Mathur MD
    Southeast Asian J Trop Med Public Health; 1999 Jun; 30(2):284-6. PubMed ID: 10774696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Investigation on TORCH infections for pregnant women and neonates in Yan'an City].
    Zhang QQ; Cheng JZ
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2012 Aug; 24(4):386, 392. PubMed ID: 23236780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening cytomegalovirus, rubella and toxoplasma infections in pregnant women with unknown pre-pregnancy serological status.
    Karacan M; Batukan M; Cebi Z; Berberoglugil M; Levent S; Kır M; Baksu A; Ozel E; Camlıbel T
    Arch Gynecol Obstet; 2014 Dec; 290(6):1115-20. PubMed ID: 25027818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seroprevalence of toxoplasma gondii, rubella virus, cytomegalovirus herpes simplex virus (TORCH) and syphilis in Jamaican pregnant women.
    Prabhakar P; Bailey A; Smikle MF; McCaw-Binns A; Ashley D
    West Indian Med J; 1991 Dec; 40(4):166-9. PubMed ID: 1664562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous Seroprevalence to
    Mocanu AG; Gorun F; Ciohat I; Navolan D; Malita D; Vilibic-Cavlek T; Dahma G; Neamtu R; Popescu D; Cioca A; Craina M
    Medicina (Kaunas); 2021 Sep; 57(9):. PubMed ID: 34577850
    [No Abstract]   [Full Text] [Related]  

  • 18. TORCH infection in women with bad obstetric history--a pilot study in Kumaon region.
    Thapliyal N; Shukla PK; Kumar B; Upadhyay S; Jain G
    Indian J Pathol Microbiol; 2005 Oct; 48(4):551-3. PubMed ID: 16366124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seroprevalence of Toxoplasma gondii, rubella and cytomegalovirus among pregnant women in southern Turkey.
    Ocak S; Zeteroglu S; Ozer C; Dolapcioglu K; Gungoren A
    Scand J Infect Dis; 2007; 39(3):231-4. PubMed ID: 17366053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serological status for TORCH in women of childbearing age: a decade-long surveillance (2012-2022) in Italy.
    Palazzotto E; Bonura F; Calà C; Capra G; Pistoia D; Mangione D; Mascarella C; Minì G; Enea M; Giammanco GM; Ferraro D; De Grazia S
    J Med Microbiol; 2023 Jul; 72(7):. PubMed ID: 37458733
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.